Evidence map›Paper›PMID 36062030›Full record

ReviewFood and bioprocess technology2023

The α-Amylase and α-Glucosidase Inhibition Capacity of Grape Pomace: A Review.

Miluska Cisneros-Yupanqui, Anna Lante, Dasha Mihaylova, Albert I Krastanov, Corrado Rizzi

Open access · hybridAbstract readReview
In one paragraph

Review in Food and bioprocess technology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Synthesis of arylated tetrahydrobenzo[Future medicinal chemistry · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Miluska Cisneros-YupanquiDepartment of Agronomy, Food, Natural Resources, Animals, and Environment -DAFNAE, Università Di Padova, Viale dell'Università, 16, Legnaro, PD 35020 Italy.ORCID 0000-0001-5516-4473
Anna LanteDepartment of Agronomy, Food, Natural Resources, Animals, and Environment -DAFNAE, Università Di Padova, Viale dell'Università, 16, Legnaro, PD 35020 Italy.ORCID 0000-0003-4709-9311
Dasha MihaylovaDepartment of Biotechnology, University of Food Technologies, 26 Maritza Blvd, 4002 Plovdiv, Bulgaria.ORCID 0000-0002-6144-9640
Albert I KrastanovDepartment of Biotechnology, University of Food Technologies, 26 Maritza Blvd, 4002 Plovdiv, Bulgaria.ORCID 0000-0003-2794-1655
Corrado RizziDepartment of Biotechnology, Università Di Verona, Strada Le Grazie 15, 37134 Verona, Italy.ORCID 0000-0002-5599-6461
University of Food Technologies · BGUniversity of Padua · ITUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The concept of functional foods is gaining more importance due to its role in maintaining a healthy status and preventing some metabolic diseases. The control of diabetes, in particular type-2 (T2DM), could be considered a big challenge since it involves other factors such as eating habits. From the pharmacological point of view, inhibiting digestive enzymes, such as α-amylase and α-glucosidase, is one of the mechanisms mainly used by synthetic drugs to control this disease; however, several side effects are described. For that reason, using bioactive compounds may appear as an alternative without presenting the complications synthetic drugs available on the market have. The winemaking industry generates tons of waste annually, and grape pomace (GP) is the most important. GP is recognized for its nutritional value and as a source of bioactive compounds that are helpful for human health. This review highlights the importance of GP as a possible source of α-amylase and α-glucosidase inhibitors. Also, it is emphasized the components involved in this bioactivity and the possible interactions among them. Especially, some phenolic compounds and fiber of GP are the main ones responsible for interfering with the human digestive enzymes. Preliminary studies in vitro confirmed this bioactivity; however, further information is required to allow the specific use of GP as a functional ingredient inside the market of products recommended for people with diabetes. Graphical abstract:

Indexed as

Antidiabetic activityFiberFunctional ingredientsGrape pomacePhenolic compoundsα-Amylase and α-glucosidase inhibition

Identifiers

PMID36062030
PMCPMC9427156
OpenAlexW4293705583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.